Legal And Market PositioningPerrigo, unlike competitors, is not entangled in litigation related to premature infant formula, positioning it favorably in the market.
Market Access ExpansionCVS Health Corp. drug plans will cover OTC oral contraceptives, a major win for Perrigo, potentially boosting market growth as other drug plans may follow suit.
Strategic Business TransformationSignificant opportunity in Perrigo's stock as it remakes itself into a best-in-class self-care company, with multiple catalysts expected as it implements its new strategy.